International Journal of Molecular Sciences (Jan 2024)

Sophoridine Counteracts Obesity via Src-Mediated Inhibition of VEGFR Expression and PI3K/AKT Phosphorylation

  • Jingchun Sun,
  • Xiaoting Wang,
  • Yulin He,
  • Xuekai Tian,
  • Tiantian Yuan,
  • Gongshe Yang,
  • Taiyong Yu

DOI
https://doi.org/10.3390/ijms25021206
Journal volume & issue
Vol. 25, no. 2
p. 1206

Abstract

Read online

Sophoridine (SRP) is a natural quinolizidine alkaloid found in many traditional Chinese herbs, though its effect on adipose tissue is unclear. We improved serum lipid levels by administering SRP by gavage in high-fat diet (HFD)-fed C57BL/6 mice. After 11 weeks, SRP supplementation significantly reduced body weight gain and improved glucose homeostasis, while reducing subcutaneous fat and liver weight. SRP also inhibited cell proliferation and differentiation of 3T3-L1 cells. Proteomics analysis revealed that SRP inhibits adipocyte differentiation by interacting with Src, thereby suppressing vascular endothelial growth factor receptor 2 (VEGFR2) expression and PI3K/AKT phosphorylation. This study provides an empirical basis for the treatment of obesity with small molecules.

Keywords